New study suggests antipsychotic use not linked to birth defects

A major study of 1.3 million women has suggested that antipsychotic use during pregnancy does not significantly increase the risk of birth defects. The research, carried out at Harvard Medical School, also found that there was no enhanced risk of cardiac malformations in particular. Exposure to antipsychotics during pregnancy is increasingly common, said the researchers. Antipsychotic medications are used for…

Read more > New study suggests antipsychotic use not linked to birth defects

Statins in pregnancy

Statin may reduce premature births in women with lipid syndrome. A drug which has been widely used in the general population to prevent cardiovascular disease appears to help prevent pregnancy complications in women with antiphospholipid syndrome, new research has found. The new statin treatment may hold promise in reducing premature births and increasing babies' chances of survival for mothers with…

Read more > Statins in pregnancy

Multivitamins for expectant mothers

  Some multivitamin and mineral supplements may be “unnecessary and expensive”, a recent study has determined. A review of the available evidence, published in this month’s issue of the Drug and Therapeutics Bulletin, found that despite strong marketing claims, the evidence suggests these do not necessarily translate into better outcomes for mother or baby. Furthermore, the researchers criticise misleading claims,…

Read more > Multivitamins for expectant mothers

Autoimmune disease in pregnancy

Autoimmune conditions, such as psoriasis, inflammatory bowel disease and rheumatoid arthritis have the potential to significantly complicate pregnancy. Both planned and unplanned pregnancies are a major issue for women with these diseases, concerned their baby may be at risk from the highly active medications they take to control their condition. Symptoms of an autoimmune disease can improve, worsen, or remain unchanged…

Read more > Autoimmune disease in pregnancy

Antiviral drug reduced hepatitis B transmission risk in pregnancy

Daily treatment with the antiviral drug tenofovir during the third trimester of pregnancy significantly reduced the risk of hepatitis B (HBV) transmission from mother to baby, according to new US research. The findings of the study could potentially help to eradicate the disease, say the researchers involved. The clinical trial was led by researchers from NYU Langone Medical Centre, who…

Read more > Antiviral drug reduced hepatitis B transmission risk in pregnancy

Survey reveals risks of medication in pregnancy “overestimated”

Pregnant women are “overestimating the risks” of taking over the counter and prescribed medication, according to new UK research carried out by pharmacists. The findings revealed that women are choosing not to treat common pregnancy symptoms such as nausea, heartburn and aches and pains with medications. It was also seen that mothers-to-be are choosing not to take medication for urinary…

Read more > Survey reveals risks of medication in pregnancy “overestimated”

Medication in pregnancy

A recent survey has found that a third of women across Europe have taken more than one medication during their pregnancy. In addition, the ‘Perceptions of Pregnancy’ survey initiated by Safe Motherhood Week found that over 94 per cent of women surveyed did not have a trouble-free pregnancy experience. The report surveyed over 3,270 women across seven countries in Europe.…

Read more > Medication in pregnancy

Load